IBDEI13Q ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,40000,1,4,0)
 ;;=4^R49.8
 ;;^UTILITY(U,$J,358.3,40000,2)
 ;;=^5019505
 ;;^UTILITY(U,$J,358.3,40001,0)
 ;;=R53.0^^148^1959^115
 ;;^UTILITY(U,$J,358.3,40001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40001,1,3,0)
 ;;=3^Malig Neop Related Fatigue
 ;;^UTILITY(U,$J,358.3,40001,1,4,0)
 ;;=4^R53.0
 ;;^UTILITY(U,$J,358.3,40001,2)
 ;;=^5019515
 ;;^UTILITY(U,$J,358.3,40002,0)
 ;;=R53.83^^148^1959^71
 ;;^UTILITY(U,$J,358.3,40002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40002,1,3,0)
 ;;=3^Fatigue NEC
 ;;^UTILITY(U,$J,358.3,40002,1,4,0)
 ;;=4^R53.83
 ;;^UTILITY(U,$J,358.3,40002,2)
 ;;=^5019520
 ;;^UTILITY(U,$J,358.3,40003,0)
 ;;=R53.1^^148^1959^163
 ;;^UTILITY(U,$J,358.3,40003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40003,1,3,0)
 ;;=3^Weakness
 ;;^UTILITY(U,$J,358.3,40003,1,4,0)
 ;;=4^R53.1
 ;;^UTILITY(U,$J,358.3,40003,2)
 ;;=^5019516
 ;;^UTILITY(U,$J,358.3,40004,0)
 ;;=R53.81^^148^1959^114
 ;;^UTILITY(U,$J,358.3,40004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40004,1,3,0)
 ;;=3^Malaise NEC
 ;;^UTILITY(U,$J,358.3,40004,1,4,0)
 ;;=4^R53.81
 ;;^UTILITY(U,$J,358.3,40004,2)
 ;;=^5019518
 ;;^UTILITY(U,$J,358.3,40005,0)
 ;;=R53.82^^148^1959^50
 ;;^UTILITY(U,$J,358.3,40005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40005,1,3,0)
 ;;=3^Chronic Fatigue,Unspec
 ;;^UTILITY(U,$J,358.3,40005,1,4,0)
 ;;=4^R53.82
 ;;^UTILITY(U,$J,358.3,40005,2)
 ;;=^5019519
 ;;^UTILITY(U,$J,358.3,40006,0)
 ;;=R54.^^148^1959^33
 ;;^UTILITY(U,$J,358.3,40006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40006,1,3,0)
 ;;=3^Age-Related Physical Debility
 ;;^UTILITY(U,$J,358.3,40006,1,4,0)
 ;;=4^R54.
 ;;^UTILITY(U,$J,358.3,40006,2)
 ;;=^5019521
 ;;^UTILITY(U,$J,358.3,40007,0)
 ;;=R60.0^^148^1959^64
 ;;^UTILITY(U,$J,358.3,40007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40007,1,3,0)
 ;;=3^Edema,Localized
 ;;^UTILITY(U,$J,358.3,40007,1,4,0)
 ;;=4^R60.0
 ;;^UTILITY(U,$J,358.3,40007,2)
 ;;=^5019532
 ;;^UTILITY(U,$J,358.3,40008,0)
 ;;=R60.1^^148^1959^63
 ;;^UTILITY(U,$J,358.3,40008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40008,1,3,0)
 ;;=3^Edema,Generalized
 ;;^UTILITY(U,$J,358.3,40008,1,4,0)
 ;;=4^R60.1
 ;;^UTILITY(U,$J,358.3,40008,2)
 ;;=^5019533
 ;;^UTILITY(U,$J,358.3,40009,0)
 ;;=R60.9^^148^1959^65
 ;;^UTILITY(U,$J,358.3,40009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40009,1,3,0)
 ;;=3^Edema,Unspec
 ;;^UTILITY(U,$J,358.3,40009,1,4,0)
 ;;=4^R60.9
 ;;^UTILITY(U,$J,358.3,40009,2)
 ;;=^5019534
 ;;^UTILITY(U,$J,358.3,40010,0)
 ;;=R61.^^148^1959^85
 ;;^UTILITY(U,$J,358.3,40010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40010,1,3,0)
 ;;=3^Hyperhidrosis,Generalized
 ;;^UTILITY(U,$J,358.3,40010,1,4,0)
 ;;=4^R61.
 ;;^UTILITY(U,$J,358.3,40010,2)
 ;;=^331970
 ;;^UTILITY(U,$J,358.3,40011,0)
 ;;=R63.0^^148^1959^36
 ;;^UTILITY(U,$J,358.3,40011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40011,1,3,0)
 ;;=3^Anorexia
 ;;^UTILITY(U,$J,358.3,40011,1,4,0)
 ;;=4^R63.0
 ;;^UTILITY(U,$J,358.3,40011,2)
 ;;=^7939
 ;;^UTILITY(U,$J,358.3,40012,0)
 ;;=R63.1^^148^1959^138
 ;;^UTILITY(U,$J,358.3,40012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40012,1,3,0)
 ;;=3^Polydipsia
 ;;^UTILITY(U,$J,358.3,40012,1,4,0)
 ;;=4^R63.1
 ;;^UTILITY(U,$J,358.3,40012,2)
 ;;=^186699
 ;;^UTILITY(U,$J,358.3,40013,0)
 ;;=R63.2^^148^1959^139
 ;;^UTILITY(U,$J,358.3,40013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40013,1,3,0)
 ;;=3^Polyphagia
 ;;^UTILITY(U,$J,358.3,40013,1,4,0)
 ;;=4^R63.2
 ;;^UTILITY(U,$J,358.3,40013,2)
 ;;=^5019540
 ;;^UTILITY(U,$J,358.3,40014,0)
 ;;=R63.3^^148^1959^72
 ;;^UTILITY(U,$J,358.3,40014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40014,1,3,0)
 ;;=3^Feeding Difficulties
 ;;^UTILITY(U,$J,358.3,40014,1,4,0)
 ;;=4^R63.3
 ;;^UTILITY(U,$J,358.3,40014,2)
 ;;=^5019541
 ;;^UTILITY(U,$J,358.3,40015,0)
 ;;=R63.4^^148^1959^29
 ;;^UTILITY(U,$J,358.3,40015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40015,1,3,0)
 ;;=3^Abnormal Weight Loss
 ;;^UTILITY(U,$J,358.3,40015,1,4,0)
 ;;=4^R63.4
 ;;^UTILITY(U,$J,358.3,40015,2)
 ;;=^5019542
 ;;^UTILITY(U,$J,358.3,40016,0)
 ;;=R63.5^^148^1959^28
 ;;^UTILITY(U,$J,358.3,40016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40016,1,3,0)
 ;;=3^Abnormal Weight Gain
 ;;^UTILITY(U,$J,358.3,40016,1,4,0)
 ;;=4^R63.5
 ;;^UTILITY(U,$J,358.3,40016,2)
 ;;=^5019543
 ;;^UTILITY(U,$J,358.3,40017,0)
 ;;=R64.^^148^1959^46
 ;;^UTILITY(U,$J,358.3,40017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40017,1,3,0)
 ;;=3^Cachexia
 ;;^UTILITY(U,$J,358.3,40017,1,4,0)
 ;;=4^R64.
 ;;^UTILITY(U,$J,358.3,40017,2)
 ;;=^17920
 ;;^UTILITY(U,$J,358.3,40018,0)
 ;;=R68.3^^148^1959^51
 ;;^UTILITY(U,$J,358.3,40018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40018,1,3,0)
 ;;=3^Clubbing of Fingers
 ;;^UTILITY(U,$J,358.3,40018,1,4,0)
 ;;=4^R68.3
 ;;^UTILITY(U,$J,358.3,40018,2)
 ;;=^5019553
 ;;^UTILITY(U,$J,358.3,40019,0)
 ;;=R73.01^^148^1959^89
 ;;^UTILITY(U,$J,358.3,40019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40019,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,40019,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,40019,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,40020,0)
 ;;=R73.02^^148^1959^90
 ;;^UTILITY(U,$J,358.3,40020,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40020,1,3,0)
 ;;=3^Impaired Glucose Tolerance (oral)
 ;;^UTILITY(U,$J,358.3,40020,1,4,0)
 ;;=4^R73.02
 ;;^UTILITY(U,$J,358.3,40020,2)
 ;;=^5019562
 ;;^UTILITY(U,$J,358.3,40021,0)
 ;;=R73.09^^148^1959^15
 ;;^UTILITY(U,$J,358.3,40021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40021,1,3,0)
 ;;=3^Abnormal Glucose NEC
 ;;^UTILITY(U,$J,358.3,40021,1,4,0)
 ;;=4^R73.09
 ;;^UTILITY(U,$J,358.3,40021,2)
 ;;=^5019563
 ;;^UTILITY(U,$J,358.3,40022,0)
 ;;=R73.9^^148^1959^84
 ;;^UTILITY(U,$J,358.3,40022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40022,1,3,0)
 ;;=3^Hyperglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,40022,1,4,0)
 ;;=4^R73.9
 ;;^UTILITY(U,$J,358.3,40022,2)
 ;;=^5019564
 ;;^UTILITY(U,$J,358.3,40023,0)
 ;;=R76.11^^148^1959^142
 ;;^UTILITY(U,$J,358.3,40023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40023,1,3,0)
 ;;=3^Positive PPD
 ;;^UTILITY(U,$J,358.3,40023,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,40023,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,40024,0)
 ;;=R79.1^^148^1959^3
 ;;^UTILITY(U,$J,358.3,40024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40024,1,3,0)
 ;;=3^Abnormal Coagulation Profile
 ;;^UTILITY(U,$J,358.3,40024,1,4,0)
 ;;=4^R79.1
 ;;^UTILITY(U,$J,358.3,40024,2)
 ;;=^5019591
 ;;^UTILITY(U,$J,358.3,40025,0)
 ;;=R82.5^^148^1959^69
 ;;^UTILITY(U,$J,358.3,40025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40025,1,3,0)
 ;;=3^Elevated Urine Levels of Drug/Meds/Biol Subst
 ;;^UTILITY(U,$J,358.3,40025,1,4,0)
 ;;=4^R82.5
 ;;^UTILITY(U,$J,358.3,40025,2)
 ;;=^5019605
 ;;^UTILITY(U,$J,358.3,40026,0)
 ;;=R82.6^^148^1959^26
 ;;^UTILITY(U,$J,358.3,40026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40026,1,3,0)
 ;;=3^Abnormal Urine Levels of Subst of Nonmed Source
 ;;^UTILITY(U,$J,358.3,40026,1,4,0)
 ;;=4^R82.6
 ;;^UTILITY(U,$J,358.3,40026,2)
 ;;=^5019606
 ;;^UTILITY(U,$J,358.3,40027,0)
 ;;=R82.7^^148^1959^27
 ;;^UTILITY(U,$J,358.3,40027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40027,1,3,0)
 ;;=3^Abnormal Urine Microbiological Findings
 ;;^UTILITY(U,$J,358.3,40027,1,4,0)
 ;;=4^R82.7
 ;;^UTILITY(U,$J,358.3,40027,2)
 ;;=^5019607
 ;;^UTILITY(U,$J,358.3,40028,0)
 ;;=R82.8^^148^1959^23
 ;;^UTILITY(U,$J,358.3,40028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40028,1,3,0)
 ;;=3^Abnormal Urine Cytology/Histology Findings
 ;;^UTILITY(U,$J,358.3,40028,1,4,0)
 ;;=4^R82.8
 ;;^UTILITY(U,$J,358.3,40028,2)
 ;;=^5019608
 ;;^UTILITY(U,$J,358.3,40029,0)
 ;;=R82.90^^148^1959^25
 ;;^UTILITY(U,$J,358.3,40029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40029,1,3,0)
 ;;=3^Abnormal Urine Findings,Unspec
 ;;^UTILITY(U,$J,358.3,40029,1,4,0)
 ;;=4^R82.90
